ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

Counseling reduces Pain, Study Shows

April 18, 1986

Early Treatment with CMX001 Can Help Prevent CMV Infection

September 27, 2013

FDA Reaction to DCT Proposals ‘Positive,’ But Chabner, Wittes ‘Disappointed’ In That Response

June 17, 1988

NCAB forms subcommittee to develop NCI biomedical technologies initiative.

September 26, 2003

Operative Laparoscopy Safe For Endometrial Cancer

April 30, 2004

Lateral Radiation Therapy Results in Regional Control In Advanced Tonsil Cancer

February 28, 2014